More hopeful and autonomous patients will want to participate more often. Physicians are not capable to guess patient preferences. The patients in the decision aid group will be better informed. The well-being of patients in the decision aid and…
ID
Bron
Verkorte titel
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.
Achtergrond van het onderzoek
Do patients with prostate cancer want to choose between radiotherapeutic radiation dose levels after being informed with a decision aid?
Prospective trial with a time series format, that is a control-intervention-control group design. The main research question is answered in a prospective design.
The evaluation of the the decision aid is done in a controlled design.
The control group receives usual care. Accrual of the control group is before and after the accrual of the intervention group.
Doel van het onderzoek
More hopeful and autonomous patients will want to participate more often. Physicians are not capable to guess patient preferences.
The patients in the decision aid group will be better informed. The well-being of patients in the decision aid and control groups will be equal.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Intervention group is usual care plus decision aid (150 patients).
Control group is usual care (150 patients), not receiving a decision aid.
Publiek
Geert Grooteplein 14A
Room 0.10
P.F.M. Stalmeier
Geert Grooteplein 14A
Nijmegen
The Netherlands
+31 (0)24 3610592
p.stalmeier@mta.umcn.nl
Wetenschappelijk
Geert Grooteplein 14A
Room 0.10
P.F.M. Stalmeier
Geert Grooteplein 14A
Nijmegen
The Netherlands
+31 (0)24 3610592
p.stalmeier@mta.umcn.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients with prostate cancer referred for radiotherapy with curative intent are eligible.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL36 |
| NTR-old | NTR63 |
| Ander register | : Dutch Cancer Society 2001-2379 |
| ISRCTN | ISRCTN97145188 |